First Time Loading...

Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 107.53 USD 0.63% Market Closed
Updated: Apr 28, 2024
Section:
 

Relative Value

The Relative Value of one ABT stock under the Base Case scenario is 123.8 USD. Compared to the current market price of 107.53 USD, Abbott Laboratories is Undervalued by 13%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ABT Relative Value
Base Case
123.8 USD
Undervaluation 13%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.6
P/S
P/S
Price to Sales
4.6
vs History
49
vs Industry
28
Median 3Y
4.7
Median 5Y
4.6
Industry
2.4
Forward
4.4
More Details
33.1
P/E
P/E
Price to Earnings
33.1
vs History
60
vs Industry
17
Median 3Y
31.5
Median 5Y
34.7
Industry
23.2
Forward
23.2
More Details
25.7
P/OCF
P/OCF
Price to OCF
25.7
vs History
25
vs Industry
16
Median 3Y
20.4
Median 5Y
22.3
Industry
15.5
More Details
92.6
P/FCFE
P/FCFE
Price to FCFE
92.6
vs History
6
vs Industry
6
Median 3Y
27.7
Median 5Y
32.5
Industry
23.5
More Details
4.8
P/B
P/B
Price to Book Value
4.8
vs History
68
vs Industry
18
Median 3Y
5.2
Median 5Y
5.2
Industry
2.2
More Details
4.8
EV/S
EV/S
Enterprise Value to Sales
4.8
vs History
65
vs Industry
25
Median 3Y
4.8
Median 5Y
4.9
Industry
2.5
Forward
4.5
More Details
8.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.7
vs History
50
vs Industry
27
Median 3Y
8.6
Median 5Y
8.6
Industry
5.2
More Details
19.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.5
vs History
57
vs Industry
17
Median 3Y
18.8
Median 5Y
20.2
Industry
12.5
Forward
17.7
More Details
29
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
29
vs History
60
vs Industry
15
Median 3Y
28
Median 5Y
30.3
Industry
17.2
Forward
20.6
More Details
26.6
EV/OCF
EV/OCF
Enterprise Value to OCF
26.6
vs History
34
vs Industry
16
Median 3Y
21.2
Median 5Y
24.7
Industry
15.1
More Details
38.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
38.1
vs History
33
vs Industry
14
Median 3Y
26.2
Median 5Y
32.8
Industry
19.7
More Details
3.1
EV/IC
EV/IC
Enterprise Value to IC
3.1
vs History
55
vs Industry
26
Median 3Y
3.3
Median 5Y
3.2
Industry
2
More Details

Multiples Across Competitors

ABT Competitors Multiples
Abbott Laboratories Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Abbott Laboratories
NYSE:ABT
186.5B USD 4.6 33.1 19.5 29
US
Intuitive Surgical Inc
NASDAQ:ISRG
133.1B USD 18.2 67 54.9 68.9
US
Stryker Corp
NYSE:SYK
127.6B USD 6.2 40.3 25.1 31.1
US
Boston Scientific Corp
NYSE:BSX
107.2B USD 7.5 68.3 31.7 47.3
IE
Medtronic PLC
NYSE:MDT
106B USD 3.3 25.2 13.5 19.1
US
Becton Dickinson and Co
NYSE:BDX
66.9B USD 3.4 54.9 18.4 38.9
DE
Siemens Healthineers AG
XETRA:SHL
59.1B EUR 2.7 38.9 18.6 31.4
US
Edwards Lifesciences Corp
NYSE:EW
52B USD 8.7 37 26.8 29
US
Dexcom Inc
NASDAQ:DXCM
47.9B USD 13.2 88.5 59.6 77.6
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
349.3B CNY 10.2 30.8 26.7 26.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.5B USD 11.3 49.1 34.5 38.1

See Also

Summary
ABT intrinsic value, competitors valuation, and company profile.
DCF Valuation
ABT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ABT stock valuation using valuation multiples.
Wall Street Estimates
ABT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ABT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.